Cas:13444-94-5 palladium(ii) bromide manufacturer & supplier

We serve Chemical Name:palladium(ii) bromide CAS:13444-94-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

palladium(ii) bromide

Chemical Name:palladium(ii) bromide
CAS.NO:13444-94-5
Synonyms:Palladium(2+) dibromide;palladium(ii) bromide;MFCD00068378;Palladium dibromide;Palladous bromide;Palladium dibromide Palladous bromide;Palladium bromide;EINECS 236-588-2
Molecular Formula:Br2Pd
Molecular Weight:266.228
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:5.173
Index of Refraction:
PSA:
Exact Mass:263.740143
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:I; II; III


Contact us for information like Palladium(2+) dibromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 236-588-2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Palladium(2+) dibromide Use and application,MFCD00068378 technical grade,usp/ep/jp grade.


Related News: ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. palladium(ii) bromide manufacturer Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. palladium(ii) bromide supplier Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). palladium(ii) bromide vendor ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. palladium(ii) bromide factory Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent).